Home / Inspections / 1049593

FDA Inspection 1049593 — Carter BloodCare at Hulen

Carter BloodCare at Hulen — FEI 3000719944

The FDA completed an inspection of Carter BloodCare at Hulen on April 13, 2018 in Fort Worth, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 13, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fort Worth, TX (United States)

Facility

Other inspections at this facility

  • 1317894 (NAI Thu Apr 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1187284 (VAI Fri Oct 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 985181 (NAI Fri Sep 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 881450 (NAI Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 800781 (NAI Thu Sep 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources